#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema with C1 esterase inhibitor deficiency Emphysema Crigler-Najjar syndrome Extra-osseous Ewing's sarcoma recurrent Immunodeficiency Myxofibrosarcoma IgA nephropathy Malignant melanoma Ductal adenocarcinoma of pancreas Spinal cord injury cervical White matter lesion Anaplastic large cell lymphoma T- and null-cell types Splenic marginal zone lymphoma Fibrodysplasia ossificans progressiva Castleman's disease More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Life with Disease Mast cell activation syndrome – Treatment Netherton’s syndrome Alternating hemiplegia of childhood – Basic Information Fragile X syndrome – Treatment Turner’s syndrome – Trials in Disease Glomerulonephritis membranous Aicardi-Goutieres syndrome – Trials in Disease Rhabdomyosarcoma – Diagnostics Mantle cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibuprofen Arginine Ulipristal Acetate Plerixafor Dazodalibep ALPROSTADIL Azd5863 Folic Acid, Anhydrous HUMAN FIBROBLASTS Agrostis Stolonifera Pollen GLYCYL-TYROSINE Erenumab Candesartan Cilexetil Elezanumab Carvedilol Lysine Hydrochloride Amcenestrant Ptg-Carcik-Cd19 Jab-21822 Remibrutinib Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Cardiac valve disease Niemann-Pick disease Hyperchylomicronaemia Crigler-Najjar syndrome Placenta praevia Porphyria non-acute Diabetic ketoacidosis Adrenoleukodystrophy Metabolic surgery Hyperparathyroidism primary Aplastic anaemia Lip and/or oral cavity cancer Transferrin decreased Cervical dysplasia Fibromyalgia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hyperkalaemia

  • A study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Patiromer
    Belgium Finland France Greece Hungary Italy +5

  • Study of sodium zirconium cyclosilicate compared to standard care for managing high blood potassium levels in patients with chronic kidney disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperkalaemia
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Spain

  • Study on the Safety and Effectiveness of Sodium Zirconium Cyclosilicate for Children with High Potassium Levels

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Germany Poland Romania Spain

  • Study on Insulin Aspart, Salbutamol, and Glucose for Treating Acute Hyperkalemia in Emergency Department Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Insulin Aspart
    • Insulin Lispro
    • Salbutamol
    France

  • Study on Sodium Zirconium Cyclosilicate for Patients with Chronic Kidney Disease Stages 3b and 4 to Allow More Fruits and Vegetables in Their Diet

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    The Netherlands

  • Study on Patiromer and Placebo for Managing Hyperkalemia in Non-Dialysis Patients with Chronic Kidney Disease Stages IIIB to V

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Calcium Polystyrene Sulfonate
    • Iohexol
    • Patiromer
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!